H. Lundbeck AS (LTS:0ND5) Total Stockholders Equity : kr22,435 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Total Stockholders Equity?

H. Lundbeck AS's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr22,435 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. H. Lundbeck AS's Book Value per Share for the quarter that ended in Mar. 2024 was kr22.62. The ratio of a company's debt over equity can be used to measure how leveraged this company is. H. Lundbeck AS's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.19.

H. Lundbeck AS Total Stockholders Equity Historical Data

The historical data trend for H. Lundbeck AS's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Total Stockholders Equity Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

16,782.00

16,973.00

18,279.00

20,779.00

22,045.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															20,980.00	21,572.00	22,305.00	22,045.00	22,435.00

H. Lundbeck AS (LTS:0ND5) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

H. Lundbeck AS's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(22435	-	0)	/	992.011
	=	22.62

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

H. Lundbeck AS's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(85	+	4078)	/	22435
	=	0.19

H. Lundbeck AS Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines